Single-arm phase 2 study to examine pembrolizumab and concurrent radiation to induce an abscopal effect in patients with previously treated carcinoma of unknown primary (CUP16-268)

Status: Closed to Accrual

Learn more:

• clinicaltrials.gov: #NCT03396471

Study Contact: studies@hoosiercancer.org; (317) 921-2050.